Abstract:Background: A significant burden of atherosclerotic disease is driven by inflammation. Recently, microRNAs (miRNAs) have emerged as important factors driving and protecting from atherosclerosis. miR-223 regulates cholesterol metabolism and inflammation via targeting both cholesterol biosynthesis pathway and NFkB signaling pathways; however, its role in atherosclerosis has not been investigated. We hypothesize that miR-223 globally regulates core inflammatory pathways in macrophages in response to inflammatory and atherogenic stimuli thus limiting the progression of atherosclerosis. Methods and results: Loss of miR-223 in macrophages decreases Abca1 gene and protein expression as well as cholesterol efflux to apoA1 (Apolipoprotein A1) and enhances proinflammatory gene expression. In contrast, overexpression of miR-223 promotes the efflux of cholesterol and macrophage polarization toward an anti-inflammatory phenotype. These beneficial effects of miR-223 are dependent on its target gene, the transcription factor Sp3. Consistent with the antiatherogenic effects of miR-223 in vitro, mice receiving miR223-/- bone marrow exhibit increased plaque size, lipid content, and circulating inflammatory cytokines (ie, IL-1β). Deficiency of miR-223 in bone marrow-derived cells also results in an increase in circulating pro-atherogenic cells (total monocytes and neutrophils) compared with control mice. Furthermore, the expression of miR-223 target gene (Sp3) and pro-inflammatory marker (Il-6) are enhanced whereas the expression of Abca1 and anti-inflammatory marker (Retnla) are reduced in aortic arches from mice lacking miR-223 in bone marrow-derived cells. In mice fed a high-cholesterol diet and in humans with unstable carotid atherosclerosis, the expression of miR-223 is increased. To further understand the molecular mechanisms underlying the effect of miR-223 on atherosclerosis in vivo, we characterized global RNA translation profile of macrophages isolated from mice receiving wild-type or miR223-/- bone marrow. Using ribosome profiling, we reveal a notable upregulation of inflammatory signaling and lipid metabolism at the translation level but less significant at the transcription level. Analysis of upregulated genes at the translation level reveal an enrichment of miR-223-binding sites, confirming that miR-223 exerts significant changes in target genes in atherogenic macrophages via altering their translation. Conclusions: Our study demonstrates that miR-223 can protect against atherosclerosis by acting as a global regulator of RNA translation of cholesterol efflux and inflammation pathways.

MicroRNA-223 Inhibits Tissue Factor Expression in Vascular Endothelial Cells

Mir-223 Inhibits Lipid Deposition And Inflammation By Suppressing Toll-Like Receptor 4 Signaling In Macrophages

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

MicroRNA-19b Functions As Potential Anti-Thrombotic Protector in Patients with Unstable Angina by Targeting Tissue Factor

MiR-223/NFAT5 Signaling Suppresses Arterial Smooth Muscle Cell Proliferation and Motility in Vitro.

miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages

MiR-106b-5p Inhibits Tumor Necrosis Factor-α-induced Apoptosis by Targeting Phosphatase and Tensin Homolog Deleted on Chromosome 10 in Vascular Endothelial Cells.

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target

Abstract 15695: Hematopoietic Deficiency of miR-223 Attenuates Thrombosis in Response to Photochemical Injury in Mice

Thrombin-activated platelet-derived exosomes regulate endothelial cell expression of ICAM-1 via microRNA-223 during the thrombosis-inflammation response

MicroRNA-29a-3p Reduces TNFα-Induced Endothelial Dysfunction by Targeting Tumor Necrosis Factor Receptor 1

The role of miR-19b in the inhibition of endothelial cell apoptosis and its relationship with coronary artery disease

MicroRNA-19b/221/222 Induces Endothelial Cell Dysfunction Via Suppression of PGC-1α in the Progression of Atherosclerosis

MicroRNA-22 Inhibition Promotes the Development of Atherosclerosis Via Targeting Interferon Regulator Factor 5.

MicroRNA-223-3p Inhibits the Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells via Affecting RPS6KB1/hif-1a Signal Pathway

An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells

Thromboangiitis Obliterans Plasma-Derived Exosomal Mir-223-5p Inhibits Cell Viability and Promotes Cell Apoptosis of Human Vascular Smooth Muscle Cells by Targeting VCAM1

MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis

Overexpression of Tissue Factor Induced Atherothrombosis in Apolipoprotein E-/- Mice Via Both Enhanced Plaque Thrombogenicity and Plaque Instability

Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration

Expression of Human Tissue Factor Pathway Inhibitor on Vascular Smooth Muscle Cells Inhibits Secretion of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerosis in ApoE −/− Mice